Sunmax Biotechnology Co Ltd (4728) — Capital Reinvestment Ratio
Sunmax Biotechnology Co Ltd (4728) has a Capital Reinvestment Ratio of 0.11x as of September 2025, meaning it reinvests 0% of its operating cash flow (NT$160.84 Million) in capital expenditures (NT$17.44 Million). Check Sunmax Biotechnology Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sunmax Biotechnology Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Sunmax Biotechnology Co Ltd's Capital Reinvestment Ratio across 9 annual periods. For the full cash flow conversion analysis, see 4728 operating cash flow.
Annual Capital Reinvestment Ratio for Sunmax Biotechnology Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Sunmax Biotechnology Co Ltd from 2016 to 2024. See 4728 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | NT$397.37 Million | NT$36.61 Million | ▼ -29.2% |
| 2023 | 0.13x | NT$848.56 Million | NT$110.39 Million | ▼ -70.7% |
| 2022 | 0.44x | NT$342.97 Million | NT$152.03 Million | ▼ -57.8% |
| 2021 | 1.05x | NT$243.28 Million | NT$255.43 Million | ▲ +212.3% |
| 2020 | 0.34x | NT$386.97 Million | NT$130.10 Million | ▲ +611.3% |
| 2019 | 0.05x | NT$289.51 Million | NT$13.68 Million | ▲ +1.0% |
| 2018 | 0.05x | NT$100.83 Million | NT$4.72 Million | ▼ -45.0% |
| 2017 | 0.09x | NT$37.09 Million | NT$3.15 Million | ▼ -70.2% |
| 2016 | 0.29x | NT$16.58 Million | NT$4.73 Million | — |